Article | 2026 Clinical Trials at the Summit
NEW DAY: Sustained-Release Steroid vs Anti-VEGF Therapy
Michael A. Singer, MD, presents data comparing a sustained-release fluocinolone acetonide implant with aflibercept in patients with retinal vascular disease.







